Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Oracle to buy Cerner for $28.3 billion in healthcare sector push

Published 12/20/2021, 09:49 AM
Updated 12/20/2021, 12:46 PM
© Reuters. FILE PHOTO: A logo of cloud service provider Oracle is seen at the company's offices at Eastpoint Business Park, Dublin, Ireland October 18, 2021. Picture taken October 18, 2021. REUTERS/Tom Bergin

By Chavi Mehta

(Reuters) - Business software maker Oracle Corp (NYSE:ORCL) said on Monday it would buy Cerner Corp (NASDAQ:CERN) for $28.3 billion in its biggest ever deal, gaining access to a trove of data from one of the biggest healthcare IT firms in the United States.

Cerner shareholders will receive $95 in cash for each share they hold, representing a premium of 5.8% to the company's last closing price.

Oracle will be able to use the data from Cerner to train and improve the software maker's artificial intelligence-based cloud services. This is likely to give Oracle an advantage and draw more healthcare clients to its cloud platform.

Cerner, whose software traditionally ran in its customers' data centers, had started shifting its service to cloud computing providers. It had selected Amazon.com Inc (NASDAQ:AMZN)'s Amazon Web Services as its "preferred" cloud provider in 2019.

However, Oracle said on Monday it will move Cerner's software to its own cloud computing service and modernize Cerner's apps with tools such as a voice assistant.

"This can be done very quickly because Cerner's largest business and most important clinical system already runs on the Oracle Database," Mike Sicilia, executive vice president for vertical industries at Oracle, said in a statement.

Amazon Web Services did not immediately respond to a Reuters request for comment.

"There is potentially some low-hanging fruit in terms of cost-saves if Oracle moves all of Cerner to Oracle's cloud," Edward Jones analyst Logan Purk said, noting that app development by customers on Oracle's cloud will make it less likely they leave for a competing platform as switching costs can be expensive.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"This minimizes customer friction while giving Oracle a leading product for healthcare customers," Purk added.

Oracle said it expects the deal, which is likely to close in 2022, to add to revenue growth as it expands Cerner's business into more countries. Cerner is expected to be accretive to earnings on an adjusted basis in the first full fiscal year and contribute "substantially more" thereafter.

Shares of Cerner were up about 1% while those of Oracle where down about 4% at $92.93.

Analysts believe healthcare has been a tough nut to crack for tech players, which have ramped up investment in the sector as demand for cloud-based solutions rose during the pandemic.

This is also indicated by Microsoft Corp (NASDAQ:MSFT)'s buyout offer for Nuance Communications (NASDAQ:NUAN) Inc as the tech giant makes a push to tap into the booming sector.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.